ReviewWorld journal of diabetes2023

Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes.

Hiroshi NomotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.